X
Thursday, May 29, 2025
Pharma Advancement
  • Home
  • Articles
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    Pharmaceutical-Chemicals Market Booms with Rising API Demand

    Pharmaceutical Chemicals Market Booms with Rising API Demand

    Next in Pharma 2025 Innovations

    Next in Pharma 2025: Innovations Shaping the Future

    Work Smart: Go for Hands-Free Lab Informatics at the Bench, Not Scribbled Notes and Delayed Documentation at Your Desk

    Clinical Development

    AI Revolutionizing Drug Discovery and Clinical Development

    Drug-Development

    China’s Super Me-Too Drug Development: A New Pharma Frontier

    Omics Based Clinical Trials

    Asia Pacific Omics-Based Clinical Trials Market Growth

    AstraZeneca Eyes Acquisition To Develop Cell Therapies

    Advanced Instruments All Set To Merge With Nova Biomedical

    Taiho Pharmaceutical Buys Araris Biotech AG For $740 Million

  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us
No Result
View All Result
  • Home
  • Articles
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    Pharmaceutical-Chemicals Market Booms with Rising API Demand

    Pharmaceutical Chemicals Market Booms with Rising API Demand

    Next in Pharma 2025 Innovations

    Next in Pharma 2025: Innovations Shaping the Future

    Work Smart: Go for Hands-Free Lab Informatics at the Bench, Not Scribbled Notes and Delayed Documentation at Your Desk

    Clinical Development

    AI Revolutionizing Drug Discovery and Clinical Development

    Drug-Development

    China’s Super Me-Too Drug Development: A New Pharma Frontier

    Omics Based Clinical Trials

    Asia Pacific Omics-Based Clinical Trials Market Growth

    AstraZeneca Eyes Acquisition To Develop Cell Therapies

    Advanced Instruments All Set To Merge With Nova Biomedical

    Taiho Pharmaceutical Buys Araris Biotech AG For $740 Million

  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us
No Result
View All Result
Pharma Advancement
No Result
View All Result
Home Drug Development

Detection of High-Risk Patients By Aortic Stability Testing

Content Team by Content Team
17th January 2023
in Drug Development, News

According to a recent study conducted in collaboration by the University of Eastern Finland and Kuopio University Hospital, patients with ascending aortic dilatation are more likely to experience pathological changes in the aortic wall when wall shear stress values derived from magnetic resonance imaging are high. In the future, high-risk patients may be identified using the data. The research is available for free in Frontiers in Physiology.

In ascending aortic dilatation, an aneurysm develops as the aorta gradually enlarges as a result of the weakened aortic wall structure. Serious consequences like aortic dissection or rupture may result from this. The bicuspid aortic valve and a few hereditary disorders are the primary risk factors for ascending aortic dilatation. There is no treatment outside surgery that is successful. Patients are usually asymptomatic, and an aneurysm is only accidentally detected or found after a life-threatening consequence. Following diagnosis, computed tomography or magnetic resonance imaging is used to periodically check the aortic dilatation.

Aorta vascular flow has also been implicated in causing alterations in the aortic wall structure and accelerating the course of disease, in addition to genetics. In patients with ascending aortic dilatation, the new study conducted at the University of Eastern Finland and Kuopio University Hospital demonstrates for the first time the relationship between wall shear stress, aortic wall strength, as well as site-specific cell composition. The findings show that changing wall shear stress in patients controls aortic degeneration, biomechanical features, and cell-driven mechanisms. The work reveals MYH10 as a novel molecular marker for pathogenic alterations in the aortic wall. Future high-risk patient detection efforts may make use of these findings.

Academy Research Fellow of the University of Eastern Finland, Johanna Laakkonen, states that the goal of her study is to find novel molecular pathways for aortic dilatation that might be used to create treatments and diagnostics for the condition. According to Professor Marja Hedman of the University of Eastern Finland and Kuopio University Hospital, they aim to find individuals with a high risk of aortic dilatation or burst and improve the follow-up of these patients, thereby minimising the risk for life-threatening complications.

Previous Post

The FDA Has Finalized Its Prescription Drug REMS Guidelines

Next Post

Addressing The Antibiotic Shortage Challenge Across Europe

Related Posts

Pharmaceutical-Chemicals Market Booms with Rising API Demand
Asia

Pharmaceutical Chemicals Market Booms with Rising API Demand

28th May 2025
Drugmakers Asked to Strictly Follow the US Pricing Reforms
Manufacturing

Drugmakers Asked to Strictly Follow the US Pricing Reforms

28th May 2025
Next in Pharma 2025 Innovations
Articles

Next in Pharma 2025: Innovations Shaping the Future

28th May 2025
Insights

Work Smart: Go for Hands-Free Lab Informatics at the Bench, Not Scribbled Notes and Delayed Documentation at Your Desk

27th May 2025
Clinical Development
Articles

AI Revolutionizing Drug Discovery and Clinical Development

19th April 2025
DHL Supply Chain
News

DHL Supply Chain comes up with New Pharma Hub in Singapore

19th April 2025
Next Post

Addressing The Antibiotic Shortage Challenge Across Europe

Qucik Links

  • Drug Development
  • Manufacturing
  • News
  • Events & Conferences
  • Newsletter Archive
Pharma Advancement

About Us

Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.

Subscribe Us

System

  • Search
  • Sitemap
  • RSS Feed

Resources

  • Advertise with us
  • Contact Us
  • Download Mediapack
  • Newsletters Archive

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

No Result
View All Result
  • Home
  • Articles
  • Drug Development
  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

Login to your account below

Forgotten Password?

Fill the forms bellow to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In

Notifications